Since 2000, we have partnered with local and international sponsors (pharmaceutical companies and research institutes such as Vertex Pharmaceuticals, AstraZeneca, and The George Institute) to deliver a range of end-to-end chronic respiratory disease services for clinical trials, which have helped to improve and save lives for people across the globe.
We have undertaken 253 trials in chronic lung disease including asthma, COPD, alpha 1-antitrypsin deficiency, bronchiectasis, idiopathic pulmonary fibrosis (IPF), cystic fibrosis, vaccines and COVID-19 home monitoring with more than 2400 patients.
We offer excellent ethics and governance processes to ensure quick start-up timeframes.
We are the largest specialised respiratory clinical trials unit within Western Australia.
We have access to world-class respiratory physicians.
We offer excellent ethics and governance processes.
Our dedicated team members are experts in respiratory medicine.
SIGN UP FOR THE INSTITUTE'S NEWSLETTER
Make sure you keep up to date with the latest discoveries to help support lung disease research.
The Clinical Trials Unit is run and operated by the Institute for Respiratory Health a registered not-for-profit. All donations of $2 and over are tax deductible in Australia.